BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33395650)

  • 1. MORPHOLOGICAL DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMORS (REVIEW AND CASE REPORT).
    Opanasenko D; Krychevska O; Kuryk O; Zakhartseva L; Rudnytska O
    Georgian Med News; 2020 Nov; (308):101-109. PubMed ID: 33395650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal Neuroendocrine Tumor with Synchronous Pancreatic Metastasis: A Case Report.
    Masuoka Y; Furukawa D; Yazawa N; Izumi H; Yamada M; Mashiko T; Saito G; Okada K; Tanaka A; Suzuki T; Sadahiro S; Hirabayashi K; Nakagohri T
    Tokai J Exp Clin Med; 2018 Jul; 43(2):38-44. PubMed ID: 29961930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
    Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
    Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine tumors: a comprehensive review.
    Zhou C; Zhang J; Zheng Y; Zhu Z
    Int J Cancer; 2012 Sep; 131(5):1013-22. PubMed ID: 22437917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
    Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
    Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
    Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
    Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters.
    ; Cho MY; Sohn JH; Jin SY; Kim H; Jung ES; Kim MJ; Kim KM; Kim WH; Kim JM; Kang YK; Choi JH; Kang DY; Kim YW; Choi EH
    Korean J Pathol; 2013 Jun; 47(3):227-37. PubMed ID: 23837015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Professional Practices and Diagnostic Issues in Neuroendocrine Tumour Pathology: Results of a Prospective One-Year Survey among French Pathologists (the PRONET Study).
    Scoazec JY; Couvelard A; Monges G; Guyétant S; Bisot-Locard S; Parot X; Lepage C;
    Neuroendocrinology; 2017; 105(1):67-76. PubMed ID: 27442514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors].
    Gao HL; Liu L; Wang WQ; Yu XJ
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):809-812. PubMed ID: 30392299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Kanakis G; Kaltsas G
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors.
    Oba A; Kudo A; Akahoshi K; Kishino M; Akashi T; Katsuta E; Iwao Y; Ono H; Mitsunori Y; Ban D; Tanaka S; Eishi Y; Tateishi U; Tanabe M
    J Gastroenterol; 2017 Oct; 52(10):1140-1146. PubMed ID: 28488114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-morphological analysis of the neuroendocrine neoplasms of the gastroenteropancreatic system.
    Delektorskaya VV; Kozlov NA; Chemeris GY
    Klin Lab Diagn; 2013 Oct; (10):48-50, 10-3. PubMed ID: 24640093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.